- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/64 - Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
Patent holdings for IPC class A61K 47/64
Total number of patents in this class: 6243
10-year publication summary
|
166
|
288
|
523
|
601
|
654
|
629
|
702
|
680
|
678
|
644
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20289 |
102 |
| Bicyclerd Limited | 149 |
77 |
| Glaxosmithkline Biologicals S.A. | 1650 |
61 |
| Mayo Foundation for Medical Education and Research | 3296 |
60 |
| Sarepta Therapeutics, Inc. | 382 |
59 |
| Pfizer Inc. | 3401 |
58 |
| Massachusetts Institute of Technology | 10143 |
58 |
| Yale University | 2444 |
50 |
| Purdue Research Foundation | 3726 |
44 |
| Bicycletx Limited | 192 |
44 |
| The Board of Trustees of the Leland Stanford Junior University | 6535 |
40 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2911 |
39 |
| Bristol-myers Squibb Company | 4820 |
38 |
| The Johns Hopkins University | 5751 |
35 |
| Ohio State Innovation Foundation | 2230 |
35 |
| Northwestern University | 3452 |
33 |
| Sapreme Technologies B.V. | 89 |
32 |
| Entrada Therapeutics, Inc. | 74 |
31 |
| Board of Regents, The University of Texas System | 5938 |
29 |
| L.e.a.f. Holdings Group LLC | 116 |
28 |
| Other owners | 5290 |